186 related articles for article (PubMed ID: 15890513)
1. Detection of CFTR mutations using ARMS and low-density microarrays.
Eaker S; Johnson M; Jenkins J; Bauer M; Little S
Biosens Bioelectron; 2005 Dec; 21(6):933-9. PubMed ID: 15890513
[TBL] [Abstract][Full Text] [Related]
2. Rapid screening for 31 mutations and polymorphisms in the cystic fibrosis transmembrane conductance regulator gene by Lminex xMAP suspension array.
Dunbar SA; Jacobson JW
Methods Mol Med; 2005; 114():147-71. PubMed ID: 16156102
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
Alibakhshi R; Zamani M
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
[TBL] [Abstract][Full Text] [Related]
5. Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.
Feriotto G; Ferlini A; Ravani A; Calzolari E; Mischiati C; Bianchi N; Gambari R
Hum Mutat; 2001; 18(1):70-81. PubMed ID: 11438995
[TBL] [Abstract][Full Text] [Related]
6. First study of CF mutations in the CFTR gene of Iranian patients: detection of DeltaF508, G542X, W1282X, A120T, R117H, and R347H mutations.
Jalalirad M; Houshmand M; Mirfakhraie R; Goharbari MH; Mirzajani F
J Trop Pediatr; 2004 Dec; 50(6):359-61. PubMed ID: 15537723
[TBL] [Abstract][Full Text] [Related]
7. Identification of the commonest cystic fibrosis transmembrane regulator gene DeltaF508 mutation: evaluation of PCR--single-strand conformational polymorphism and polyacrylamide gel electrophoresis.
Kakavas KV; Noulas AV; Kanakis I; Bonanou S; Karamanos NK
Biomed Chromatogr; 2006 Oct; 20(10):1120-5. PubMed ID: 16708396
[TBL] [Abstract][Full Text] [Related]
8. Multiplex allele-specific target amplification based on PCR suppression.
Broude NE; Zhang L; Woodward K; Englert D; Cantor CR
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):206-11. PubMed ID: 11136256
[TBL] [Abstract][Full Text] [Related]
9. Allele-specific competitive blocker PCR: a one-step method with applicability to pool screening.
Orou A; Fechner B; Utermann G; Menzel HJ
Hum Mutat; 1995; 6(2):163-9. PubMed ID: 7581400
[TBL] [Abstract][Full Text] [Related]
10. An alternative method to amplify RNA without loss of signal conservation for expression analysis with a proteinase DNA microarray in the ArrayTube format.
Schüler S; Wenz I; Wiederanders B; Slickers P; Ehricht R
BMC Genomics; 2006 Jun; 7():144. PubMed ID: 16768788
[TBL] [Abstract][Full Text] [Related]
11. Genotyping of mutation in the beta-globin gene using DNA microarrays.
Dufva M; Poulsen L
Methods Mol Biol; 2009; 509():47-56. PubMed ID: 19212714
[TBL] [Abstract][Full Text] [Related]
12. Array-based mutation detection of BRCA1 using direct probe/target hybridization.
Yim SC; Park HG; Chang HN; Cho DY
Anal Biochem; 2005 Feb; 337(2):332-7. PubMed ID: 15691514
[TBL] [Abstract][Full Text] [Related]
13. On-chip oligonucleotide ligation assay using one-dimensional microfluidic beads array for the detection of low-abundant DNA point mutations.
Zhang H; Yang X; Wang K; Tan W; Li H; Zuo X; Wen J
Biosens Bioelectron; 2008 Feb; 23(7):945-51. PubMed ID: 17983740
[TBL] [Abstract][Full Text] [Related]
14. Microchamber array based DNA quantification and specific sequence detection from a single copy via PCR in nanoliter volumes.
Matsubara Y; Kerman K; Kobayashi M; Yamamura S; Morita Y; Tamiya E
Biosens Bioelectron; 2005 Feb; 20(8):1482-90. PubMed ID: 15626601
[TBL] [Abstract][Full Text] [Related]
15. A novel optical biosensor format for the detection of clinically relevant TP53 mutations.
Wilson PK; Jiang T; Minunni ME; Turner AP; Mascini M
Biosens Bioelectron; 2005 May; 20(11):2310-3. PubMed ID: 15797331
[TBL] [Abstract][Full Text] [Related]
16. Microarray analysis in cystic fibrosis.
Galvin P; Clarke LA; Harvey S; Amaral MD
J Cyst Fibros; 2004 Aug; 3 Suppl 2():29-33. PubMed ID: 15463921
[TBL] [Abstract][Full Text] [Related]
17. Four-color multiplex 5' nuclease assay for the simultaneous detection of the factor V Leiden and the prothrombin G20210A mutations.
Ugozzoli LA; Hamby K
Mol Cell Probes; 2004 Jun; 18(3):161-6. PubMed ID: 15135449
[TBL] [Abstract][Full Text] [Related]
18. Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis.
Takahashi Y; Seki N; Ishiura H; Mitsui J; Matsukawa T; Kishino A; Onodera O; Aoki M; Shimozawa N; Murayama S; Itoyama Y; Suzuki Y; Sobue G; Nishizawa M; Goto J; Tsuji S
Arch Neurol; 2008 Oct; 65(10):1326-32. PubMed ID: 18852346
[TBL] [Abstract][Full Text] [Related]
19. DNA microarrays.
Bier FF; von Nickisch-Rosenegk M; Ehrentreich-Förster E; Reiss E; Henkel J; Strehlow R; Andresen D
Adv Biochem Eng Biotechnol; 2008; 109():433-53. PubMed ID: 17985099
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 31 CFTR mutations by polymerase chain reaction/oligonucleotide ligation assay in a pilot screening of 4476 newborns for cystic fibrosis.
Gasparini P; Arbustini E; Restagno G; Zelante L; Stanziale P; Gatta L; Sbaiz L; Sedita AM; Banchieri N; Sapone L; Fiorucci GC; Brinson E; Shulse E; Rappaport E; Fortina P
J Med Screen; 1999; 6(2):67-9. PubMed ID: 10444722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
